CAV 1 & 2 (Canine Hepatitis) Positive Control

Description

Isotype or positive controls by peptides, antibodies and deactivated samples. Hepatitis a, b, c, d, e recombinant surface viral antigens to genotype 1, 2, 3, 4, 5 are used for antibody production to make diagnostic poly or monoclonal antibodies. Hepatitis is a disease of the liver characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis may occur without symptoms, but can lead to jaundice (a yellow discoloration of the skin, mucous membranes, and conjunctiva of the eyes), poor appetite, and fatigue. Depending on the cause, hepatitis can manifest either as an acute or as a chronic disease. Positive controls are the same as the target vector or antibody or protein and can be spiked to the sample before the analysis starts.
Group

positif

Gene target

CAV Hepatitis
Gene symbol

CAV2, CAV1, CA5A
Short name

CAV 1 & 2 ( Hepatitis) Positive Control
Technique

Positive, Control, controls
Species

From Canis lupus or the domestic dog we know mostly the Beagle to be used in drug discovery experiments.
Alternative name

CAV 1 & 2 (canine Hepatitis) Positive reference
Alternative technique

controls
Tissue

control
Virus

hepatitis

Identity

HGNC:1527
Gene

CAV1
Long gene name

caveolin 1
Synonyms gene
- CAV
Synonyms gene name
- caveolin 1, caveolae protein, 22kD
- caveolin 1, caveolae protein, 22kDa
GenBank acession
- AF125348
Locus

7q31.2
Discovery year

1993-11-02
Entrez gene record

857
Pubmed identfication
- 10087206
RefSeq identity
- NM_001753
Classification
- Caveolins
VEGA ID

OTTHUMG00000023413